透析患者中酶联免疫吸附测定法（ELISA）与重组免疫印迹法4代（RIBA 4）检测抗丙型肝炎病毒的比较：我们的经验
Comparison of anti-hepatitis C virus detection with ELISA assay and RIBA 4 in dialysis patients: our experience.
作者信息
Innocenti M, Mazzoni A, Moretti A, Palla P
机构信息
Nephrology Unit, Livorno, Italy.
出版信息
Nephron. 1992;61(3):315. doi: 10.1159/000186919.
Hepatitis C virus (HCV) has been demonstrated to be the main cause of non-A, non-B hepatitis and the emergent infectious illness in dialysis units. At present, the anti-HCV 100 ELISA and an immunoblot assay in which 2 new antigens are included, are available. We have tested 110 patients on chronic dialysis with anti-C100 ELISA. Twenty-seven of them were anti-HCV positive. We tested the 27 anti-HCV-positive and 7 anti-HCV-negative patients with the RIBA 4 assay. The results were similar with both test.
丙型肝炎病毒（HCV）已被证实是非甲非乙型肝炎的主要病因以及透析单位中出现的传染病病因。目前，有抗-HCV 100 ELISA和一种包含2种新抗原的免疫印迹法可供使用。我们用抗-C100 ELISA检测了110例慢性透析患者。其中27例抗-HCV呈阳性。我们用RIBA 4检测法对这27例抗-HCV阳性患者和7例抗-HCV阴性患者进行了检测。两种检测的结果相似。
Zotero 插件